A brief review of the current breast cancer prevention trials and proposals for future trials
- 1 June 2000
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (10) , 1298-1302
- https://doi.org/10.1016/s0959-8049(00)00106-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJournal of Clinical Oncology, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer and Clinical Oncology, 1990
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985